Enbio Co Ltd (352940)

KOSDAQ

Currency in KRW

2,280

-25(-1.08%)

Closed·07:29:59

Fair Value

Unlock Value

Day's Range

2,255

2,320

52 wk Range

1,965

2,800

352940 Financial Summary

A brief financial summary of Enbio Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio181.77

Price/Book0.58

Debt / Equity37.35%

Return on Equity0.32%

Dividend Yield0.00%

EBITDA3.16B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

34,563.13

33,466.01

34,239.81

34,024.28

35,654.03

Gross Profit

aa.aa

14,332.27

10,752.66

6,341.96

7,054.52

11,572.61

Operating Income

aa.aa

4,095.56

1,121.78

-4,777.39

-3,353.97

1,378.14

Net Income

aa.aa

-4,449.45

5,245.05

-3,444.68

-6,300.32

645.61

Balance Sheet

Total Assets

aa.aa

71,477.18

90,604.74

87,359.61

66,318.57

67,771.22

Total Current Liabilities

aa.aa

33,394.15

38,242.29

39,046.74

25,067.19

21,944.87

Total Equity

aa.aa

36,953.87

49,915.29

46,488.48

40,726.11

41,371.72

Cash Flow

Levered Free Cash Flow

aa.aa

7,902.55

-6,597.02

-11,518.53

2,725.5

-3,294.89

Cash from Operations

aa.aa

3,798.9

-2,289.15

-8,498.88

10,920.63

4,901.38

Cash from Investing

aa.aa

-1,164.19

-5,536.52

-2,653.01

1,042.51

-7,999.51

Cash from Financing

aa.aa

6,135.59

21,349.76

94.07

-20,370.85

1,140.26

Net Change in Cash

aa.aa

8,768.48

13,524.18

-11,059.26

-8,398.21

-1,957.64

* In Millions of KRW (except for per share items)

Earnings

Latest Release

Jul 30, 2025

EPS / Forecast

17.00 / --

Revenue / Forecast

8.53B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Enbio's earnings for the latest quarter?

The Enbio EPS (TTM) is 13.04. Enbio reported sales of 8,525.28, net income of 182.09, and EPS of 17.00 for the latest quarter.

What was Enbio's net income for the latest quarter?

Enbio's net income for the latest quarter was 182.09.

How did Enbio's performance compare year-over-year in the latest quarter?

The company's revenue moved from 13,830.38 in the previous quarter to 8,525.28 in the latest quarter, and net income moved from 2,415.70 to 182.09 compared to the previous quarter.

What is Enbio's net profit margin on a TTM basis?

Enbio's trailing twelve months (TTM) net profit margin is 1.81%.

How does Enbio's debt to equity ratio compare to industry standards?

Enbio's total debt-to-equity ratio is 37.35%.

What is Enbio's return on investment on a TTM basis?

Enbio's trailing twelve months (TTM) return on investment (ROI) is 0.32%.

Did Enbio gain or lose cash last quarter?

In the latest quarter, Enbio's net change in cash was 177.32 million.

What were Enbio's total assets and liabilities in the latest quarter?

As of the latest quarter, Enbio reported total assets of 69,897.62 million and total liabilities of 20,664.99 million.

How has Enbio's total revenue grown this year?

Enbio's total revenue was 13,830.38 in the previous quarter and 8,525.28 in the latest quarter.

What is Enbio's gross margin on a TTM basis?

Enbio's trailing twelve months (TTM) gross margin is 31.12%.

What was Enbio's revenue per share for the latest quarter?

Enbio's revenue per share for the latest quarter was 48,575.35.

NSE 30

5,153.20

+13.27

+0.26%

NSE All Share

141,430.28

+426.14

+0.30%

US 30

45,502.00

-129.7

-0.28%

US 500

6,452.00

-14.9

-0.23%

FTSE 100

9,321.40

+12.20

+0.13%

DAX

24,331.91

-38.83

-0.16%

South Africa Top 40

95,357.01

+290.15

+0.31%

Market Movers

Name	Last	Chg. %	Vol.
Guaranty Trust Holding	96.05	+2.18%	24.95M
UBA	48.00	+0.10%	14.20M
Access Holdings	27.30	+1.11%	14.17M
Zenith Bank	69.65	-0.50%	10.11M
Aradel Holdings	501.50	-3.37%	2.66M
Julius Berger	142.90	+7.52%	2.15M
MTN Nigeria	409.00	-5.98%	700.86K

Name	Last	Chg. %	Vol.
John Holt PLC	7.70	+10.00%	38.95K
Austin Laz	3.19	+10.00%	2.57M
Infinity Trust Mortgage Bank	7.70	+10.00%	100.00
Airtel Africa	2,541.50	+10.00%	102.00
SCOA Nigeria	6.050	+10.00%	27.55K
Livingtrust Mortgage Bank	4.62	+10.00%	2.96K
Cutix	3.900	+9.86%	2.13M

Name	Last	Chg. %	Vol.
Tripple Gee and Co	5.04	-10.00%	26.38K
Geregu Power	1,027.40	-10.00%	6.89K
Okomu Oil Palm	918.00	-10.00%	155.15K
Total Nig	576.00	-10.00%	35.66K
Chellarams	9.45	-10.00%	21.13K
Transcorp Power	257.90	-9.98%	269.69K
Transexpr	1.94	-9.77%	531.00

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	409.00	-5.98%	700.86K
Mutual Benefits Assurance	4.49	+2.05%	17.93M
Aiico	4.40	+5.26%	26.10M
Dangote Cement	517.90	-0.40%	111.38K
Betaglas	475.00	+5.71%	117.48K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaaa Aaa	5,450.00	+46.90%	8,006.05
Aaaaaaaaaaaaaa	517.90	+35.88%	703.72
Aaaaaaaaaaaaa	140.00	+31.85%	184.59
Aa A Aa Aaaaaaaa	1,800.20	+30.65%	2,351.96
Aaaaaaa A	64.10	+18.13%	75.72
A A Aaa Aaaaaaaaa	576.00	+17.25%	675.36

Name	Last	Upside	Fair Value
Aa Aaaaaaaaa Aaa	5,450.00	+46.90%	8,006.05
Aaaaaaaaaaaaaa	517.90	+35.88%	703.72
Aaaaaaaaaaaaa	140.00	+31.85%	184.59
Aa A Aa Aaaaaaaa	1,800.20	+30.65%	2,351.96
Aaaaaaa A	64.10	+18.13%	75.72
A A Aaa Aaaaaaaaa	576.00	+17.25%	675.36

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Enbio Co Ltd (352940)

352940 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Enbio's earnings for the latest quarter?

What was Enbio's net income for the latest quarter?

How did Enbio's performance compare year-over-year in the latest quarter?

What is Enbio's net profit margin on a TTM basis?

How does Enbio's debt to equity ratio compare to industry standards?

What is Enbio's return on investment on a TTM basis?

Did Enbio gain or lose cash last quarter?

What were Enbio's total assets and liabilities in the latest quarter?

How has Enbio's total revenue grown this year?

What is Enbio's gross margin on a TTM basis?

What was Enbio's revenue per share for the latest quarter?

Trending Stocks